AIM

AIM ImmunoTech Inc
AMEX

Real-time Quotes | Nasdaq Last Sale

2.520
-0.050
-1.95%
After Hours: 2.490 -0.03 -1.19% 16:31 07/13 EDT
OPEN
2.560
PREV CLOSE
2.570
HIGH
2.640
LOW
2.470
VOLUME
4.13M
TURNOVER
--
52 WEEK HIGH
7.11
52 WEEK LOW
0.3810
MARKET CAP
82.21M
P/E (TTM)
-0.9874
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average AIM stock price target is 6.17 with a high estimate of 7.00 and a low estimate of 5.00.

EPS

AIM News

More
AIM ImmunoTech teams up with Roswell Park for combo trial in COVID-19 patients with cancer
Seeking Alpha - Article · 4d ago
Peacock licenses ViacomCBS programs for streaming
Seeking Alpha - Article · 07/01 15:05
Bernstein upgrades Comcast and urges spin-out of NBCUniversal, Sky
Seeking Alpha - Article · 07/01 13:25
What to watch today: Dow cut losses after best quarter in over three decades
Dow futures erase losses and turn positive Wednesday on positive results from a coronavirus vaccine trial.
CNBC.com · 07/01 13:03
Stocks making the biggest moves in the premarket: Macy's, United, FedEx, Boeing, Facebook & more
The stocks making the biggest moves in premarket trading include Macy's, United, FedEx, Boeing, Facebook, and more.
CNBC.com · 07/01 11:59
Google raises price of YouTube TV, its cable-like bundle, to $65 a month
The latest bump shows streaming services struggling to compete with cable prices despite being touted as a solution for cable-cutting.
CNBC.com · 06/30 17:31
AIM ImmunoTech Issues Press Release Announces the Company was Added to the Russell 2000 Index
Benzinga · 06/29 10:56
INO, DVAX among premarket gainers
Seeking Alpha - Article · 06/26 12:21

Industry

Biotechnology & Medical Research
-1.77%
Pharmaceuticals & Medical Research
-0.19%

Hot Stocks

Symbol
Price
%Change

About AIM

AIM ImmunoTech Inc., formerly Hemispherx Biopharma, Inc., is a specialty pharmaceutical company. The Company is engaged in the clinical development of drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company's segment is engaged in research and development activities related to Ampligen and other drugs under development, and sales and marketing of Alferon. The Company's products include Alferon N Injection and Ampligen. Alferon N Injection is approved for the use in intralesional treatment of refractory or recurring external genital warts in patients of over 18 years of age. Ampligen is a drug undergoing clinical development for the treatment of Chronic Fatigue Syndrome (CFS). Alferon LDO (Low Dose Oral Interferon Alfa-n3 (Human Leukocyte Derived)) is a low-dose, oral liquid formulation of natural alpha interferon. Alferon LDO is a liquid natural interferon for oral administration.
More

Webull offers kinds of AIM ImmunoTech Inc stock information, including AMEX:AIM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AIM stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AIM stock methods without spending real money on the virtual paper trading platform.